{"filing":{"accession_number":"0001493152-26-026452","cik":"0002030763","ticker":"WGRX","company_name":"Wellgistics Health, Inc.","form":"8-K","filing_date":"2026-05-29","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2030763/000149315226026452/form8-k.htm"},"events":[{"id":8223,"run_id":7214,"accession_number":"0001493152-26-026452","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses a Securities Purchase Agreement dated May 27, 2026, under which Wellgistics Health issued convertible promissory notes with an aggregate principal amount of $21.1 million and warrants to accredited investors for $16.9 million in cash. The Notes are convertible into common stock at prices ranging from $1.00 to $6.00 per share, and the PIPE Warrants are exercisable at $7.50 per share, with potential gross proceeds of approximately $42.8 million if fully exercised. This is a classic PIPE (private investment in public equity) transaction involving dilutive securities that require stockholder approval under Nasdaq Listing Rule 5635(d) and impose an Exchange Cap of 19.99% of outstanding shares.","company_name":"Wellgistics Health, Inc.","ticker":"WGRX","filing_date":"2026-05-29","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":2852,"accession_number":"0001493152-26-026452","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a Securities Purchase Agreement dated May 27, 2026, under which Wellgistics Health issued convertible promissory notes with an aggregate principal amount of $21.1 million and warrants to accredited investors for $16.9 million in cash. The Notes are convertible into common stock at prices ranging from $1.00 to $6.00 per share, and the PIPE Warrants are exercisable at $7.50 per share, with potential gross proceeds of approximately $42.8 million if fully exercised. This is a classic PIPE (private investment in public equity) transaction involving dilutive securities that require stockholder approval under Nasdaq Listing Rule 5635(d) and impose an Exchange Cap of 19.99% of outstanding shares.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:37:49.411499+00:00","company_name":"Wellgistics Health, Inc.","ticker":"WGRX","filing_date":"2026-05-29"}]}